The Pistoia Alliance is a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in Life Science R&D and healthcare.
The Pistoia Alliance is keen to reach out to the vibrant life science community in Singapore for knowledge sharing.
In pursuance of this mission, the Pistoia Alliance is holding a “lunch & learn” meeting on Thursday 31st January 2019. The Pistoia Alliance will set out to explain the projects and the other activities in which it is currently engaged, and also what it is planning to do in the near future. The Pistoia Alliance is particularly keen to learn how it can shape its activities such that it can be increasingly relevant to the life science community in Singapore
This meeting will be hosted by Merck (a member of the Pistoia Alliance) at their MSD Singapore IT Hub at: 1 Fusionopolis Pl, Singapore 138522
DRAFT Agenda – Thursday 31st January 2019 – REGISTER
10:00 Opening remarks / Julie Olszewski, ED of IT Innovation Hub and Data Science at MSD
10:10 Introduction of the Pistoia Alliance including: Strategic Themes, Projects, Communities of Interest, Conferences, Workshops, Symposia, Webinars, Publications, Start-up Company Challenges, Hackathons, etc. / Ashley George & John Wise, Pistoia Alliance
10:40 Partnerships in Research / Dr Yee Leong Teoh, Chief Executive Officer, Clinical Research Institute Pte Ltd
11:00 Singapore’s approach to precision medicine and the Asian phenotype / Dr Patrick Tan, Deputy ED of the Biomedical Research Council and co-chair of the National Precision Medicine Steering Committee
11:20 Pharmaceutical manufacturing – the Factory of the Future (including API, biologics & cell Rx manufacturing) / Dr Danny Soon, Senior Director, Biomedical Research Council
11:40 Coffee Break
12:00 Innovation in Life Science R&D: South-East Asia Perspective / Rahul Pandey, Healthcare and IP Consultant Clarivate Analytics
12:20 Pre-Competitive Collaboration in Singapore – the Merck Perspective / Eric Gifford, Director MRL IT & Hal Stern, AVP, IT Engineering, Merck Research Labs
12:40 The Next Generation of Clinical Trials / Kate Lawrey, Associate Director, Asia Analytics Operations Lead and Regional Site Identification Oversight at IQVIA
13:00 Discussion and plans for next steps
14:30 Meeting Close